Lei Tang, Jun Zhao, Rongyuan Liang, Jiale Yang, Caiwei Chen, Zhonghuo Chen, Xiaofei Tao, Jianwei Yi, Taozhi Yu, Kai Wang
{"title":"HAUS1-mediated activation of CDK4 transcription enhances proliferation, invasion and migration in hepatocellular carcinoma.","authors":"Lei Tang, Jun Zhao, Rongyuan Liang, Jiale Yang, Caiwei Chen, Zhonghuo Chen, Xiaofei Tao, Jianwei Yi, Taozhi Yu, Kai Wang","doi":"10.1038/s41417-026-01014-x","DOIUrl":null,"url":null,"abstract":"<p><p>Hepatocellular carcinoma (HCC) is distinguished by aggressive proliferation, invasion, and migration, with its underlying molecular mechanisms remaining largely elusive.This study delves into the molecular mechanisms underlying HAUS1's role in HCC progression, focusing on its regulatory relationship with Cyclin-Dependent Kinase 4 (CDK4). We analyzed 34 HCC tissue specimens and conducted in vitro assays to evaluate HAUS1's impact on cell proliferation, invasion, migration, cycle and apoptosis. Potential molecules regulated by HAUS1 that could influence HCC function were further screened. Notably, HAUS1 was shown to activate CDK4 (Cyclin-Dependent Kinase 4) transcription, establishing a regulatory nexus where HAUS1-induced CDK4 expression exacerbates HCC malignancy. In vivo studies reinforced these findings, evidencing that HAUS1 influences tumor growth in xenograft models. Collectively, our research elucidates HAUS1's oncogenic role in HCC, mediated through CDK4 activation, and highlights its potential as a therapeutic target in HCC therapy. Mechanistic diagram illustrating how HAUS1 activates CDK4 transcription to promote proliferation, invasion and migration in HCC.</p>","PeriodicalId":9577,"journal":{"name":"Cancer gene therapy","volume":" ","pages":""},"PeriodicalIF":5.0000,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer gene therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41417-026-01014-x","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Hepatocellular carcinoma (HCC) is distinguished by aggressive proliferation, invasion, and migration, with its underlying molecular mechanisms remaining largely elusive.This study delves into the molecular mechanisms underlying HAUS1's role in HCC progression, focusing on its regulatory relationship with Cyclin-Dependent Kinase 4 (CDK4). We analyzed 34 HCC tissue specimens and conducted in vitro assays to evaluate HAUS1's impact on cell proliferation, invasion, migration, cycle and apoptosis. Potential molecules regulated by HAUS1 that could influence HCC function were further screened. Notably, HAUS1 was shown to activate CDK4 (Cyclin-Dependent Kinase 4) transcription, establishing a regulatory nexus where HAUS1-induced CDK4 expression exacerbates HCC malignancy. In vivo studies reinforced these findings, evidencing that HAUS1 influences tumor growth in xenograft models. Collectively, our research elucidates HAUS1's oncogenic role in HCC, mediated through CDK4 activation, and highlights its potential as a therapeutic target in HCC therapy. Mechanistic diagram illustrating how HAUS1 activates CDK4 transcription to promote proliferation, invasion and migration in HCC.
期刊介绍:
Cancer Gene Therapy is the essential gene and cellular therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene and cellular therapies for cancer. The journal publishes original laboratory and clinical research papers, case reports and review articles. Publication topics include RNAi approaches, drug resistance, hematopoietic progenitor cell gene transfer, cancer stem cells, cellular therapies, homologous recombination, ribozyme technology, antisense technology, tumor immunotherapy and tumor suppressors, translational research, cancer therapy, gene delivery systems (viral and non-viral), anti-gene therapy (antisense, siRNA & ribozymes), apoptosis; mechanisms and therapies, vaccine development, immunology and immunotherapy, DNA synthesis and repair.
Cancer Gene Therapy publishes the results of laboratory investigations, preclinical studies, and clinical trials in the field of gene transfer/gene therapy and cellular therapies as applied to cancer research. Types of articles published include original research articles; case reports; brief communications; review articles in the main fields of drug resistance/sensitivity, gene therapy, cellular therapy, tumor suppressor and anti-oncogene therapy, cytokine/tumor immunotherapy, etc.; industry perspectives; and letters to the editor.